Review demonstrates therapeutic benefits of biologics for managing aspirin-exacerbated respiratory disease in adult asthmatics, highlighting targeted interventions for severe disease subtypes.
Aspirin-exacerbated respiratory disease (AERD) affects approximately 7% of adult asthmatics, with the prevalence doubling among those with severe asthma (SA) and reaching up to 30% of patients w...
No takes yet. Share an insight, caveat, or question.
Nedeva et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: